CIA
CLB icon

Cape Investment Advisory’s Core Laboratories CLB Stock Holding History

Cape Investment Advisory’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-178
Closed -$2.05K – 912
2025
Q2 		$2.05K Buy
178
+48
+37% +$569 ﹤0.01% 935
2025
Q1 		$1.95K Sell
130
-42
-24% -$703 ﹤0.01% 895
2024
Q4 		$2.98K Hold
172
– – ﹤0.01% 832
2024
Q3 		$3.19K Sell
172
-191
-53% -$3.84K ﹤0.01% 775
2024
Q2 		$7.37K Buy
363
+146
+67% +$2.58K ﹤0.01% 577
2024
Q1 		$3.71K Buy
217
+98
+82% +$1.54K ﹤0.01% 695
2023
Q4 		$2.1K Hold
119
– – ﹤0.01% 914
2023
Q3 		$2.86K Hold
119
– – ﹤0.01% 756
2023
Q2 		$2.77K Buy
+119
New +$2.69K ﹤0.01% 743

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Cape Investment Advisory's CLB Position: Q3 2025 in Review

Cape Investment Advisory sold out of Core Laboratories (CLB) in Q3 2025, closing a stake of 178 shares — an estimated $2.05K sold.

Cape Investment Advisory first reported a position in CLB in Q2 2023 and held it in 9 quarters. The position peaked at $7.37K in Q2 2024. 190 funds tracked by Wall St. Rank hold CLB as of Q3 2025.

  • Cape Investment Advisory reported no remaining Core Laboratories position as of Q3 2025 after selling out during the quarter.
  • Cape Investment Advisory sold 178 Core Laboratories shares in Q3 2025, an estimated $2.05K.
  • Cape Investment Advisory first reported a position in Core Laboratories in Q2 2023 and held it in 9 quarters.
  • Cape Investment Advisory's Core Laboratories position peaked at $7.37K in Q2 2024.
  • 190 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2025.

Based on Cape Investment Advisory's 13F filing for Q3 2025, filed 29 Dec 2025.